Table 2

Clinical features of the 836 patients who were examined at ≥60 years according to age at first syncope

Clinical featuresFirst syncopeP-value
<30 years (n = 100)30–59 years (n = 151)≥60 years (n = 585)<30 vs. 30–59 years<30 vs. ≥60 years30–59 vs. ≥60 years
Female sex, n (%)71 (71)83 (55)276 (47)0.011<0.0010.088
Age at investigation, median (IQR)70 (65–75)64 (61–70)74 (69–80)<0.001<0.001<0.001
Years between first syncope and investigation, median (IQR)54 (46–60)11 (5–20)2 (1–5)<0.001<0.001<0.001
Total no. of syncopes, median (IQR)8 (3–20)6 (3–10)3 (2–6)0.001<0.0010.003
Supine SBP, mean ± SD145 ± 19141 ± 22144 ± 230.2560.9100.143
Supine DBP, mean ± SD77 ± 1175 ± 1274 ± 120.3160.0260.222
Supine HR, mean ± SD70 ± 1270 ± 1270 ± 120.8040.6890.902
Prodromes, n (%)51 (52)52 (34)149 (26)0.020<0.0010.113
Palpitations, n (%)13 (13)28 (19)71 (12)0.1460.1860.136
Dizziness upon standing, n (%)69 (69)98 (65)398 (68)0.5000.8840.431
Hypertension, n (%)40 (40)70 (47)341 (59)0.3070.0010.009
History of CAD, n (%)8 (8)15 (10)79 (14)0.6090.1290.241
Heart failure, n (%)2 (2)8 (5)50 (9)0.1980.0240.186
Atrial fibrillation, n (%)9 (9)13 (9)113 (20)0.9210.0130.002
VVS, n (%)39 (39)47 (31)108 (19)0.198<0.0010.001
OH, n (%)7 (7)21 (14)133 (23)0.089<0.0010.017
CSS/CSH, n (%)4 (4)8 (5)54 (9)0.6370.0820.120
Complex syncope, n (%)37 (37)45 (30)152 (26)0.2340.0230.351
PPS, n (%)0 (0)1 (1)1 (0.2)0.4150.6970.302
No diagnosis, n (%)13 (13)29 (19)135 (23)0.1970.0230.299
Clinical featuresFirst syncopeP-value
<30 years (n = 100)30–59 years (n = 151)≥60 years (n = 585)<30 vs. 30–59 years<30 vs. ≥60 years30–59 vs. ≥60 years
Female sex, n (%)71 (71)83 (55)276 (47)0.011<0.0010.088
Age at investigation, median (IQR)70 (65–75)64 (61–70)74 (69–80)<0.001<0.001<0.001
Years between first syncope and investigation, median (IQR)54 (46–60)11 (5–20)2 (1–5)<0.001<0.001<0.001
Total no. of syncopes, median (IQR)8 (3–20)6 (3–10)3 (2–6)0.001<0.0010.003
Supine SBP, mean ± SD145 ± 19141 ± 22144 ± 230.2560.9100.143
Supine DBP, mean ± SD77 ± 1175 ± 1274 ± 120.3160.0260.222
Supine HR, mean ± SD70 ± 1270 ± 1270 ± 120.8040.6890.902
Prodromes, n (%)51 (52)52 (34)149 (26)0.020<0.0010.113
Palpitations, n (%)13 (13)28 (19)71 (12)0.1460.1860.136
Dizziness upon standing, n (%)69 (69)98 (65)398 (68)0.5000.8840.431
Hypertension, n (%)40 (40)70 (47)341 (59)0.3070.0010.009
History of CAD, n (%)8 (8)15 (10)79 (14)0.6090.1290.241
Heart failure, n (%)2 (2)8 (5)50 (9)0.1980.0240.186
Atrial fibrillation, n (%)9 (9)13 (9)113 (20)0.9210.0130.002
VVS, n (%)39 (39)47 (31)108 (19)0.198<0.0010.001
OH, n (%)7 (7)21 (14)133 (23)0.089<0.0010.017
CSS/CSH, n (%)4 (4)8 (5)54 (9)0.6370.0820.120
Complex syncope, n (%)37 (37)45 (30)152 (26)0.2340.0230.351
PPS, n (%)0 (0)1 (1)1 (0.2)0.4150.6970.302
No diagnosis, n (%)13 (13)29 (19)135 (23)0.1970.0230.299

The Bonferroni-adjusted significance level was set at P = 0.017.

SBP, systolic blood pressure; DBP, diastolic blood pressure; HR, heart rate; CAD, coronary artery disease; VVS, vasovagal syncope; OH, orthostatic hypotension; CSH, carotid sinus hypersensitivity; CSS, carotid sinus syndrome; PPS, psychogenic pseudosyncope; SD, standard deviation; IQR, interquartile range.

Table 2

Clinical features of the 836 patients who were examined at ≥60 years according to age at first syncope

Clinical featuresFirst syncopeP-value
<30 years (n = 100)30–59 years (n = 151)≥60 years (n = 585)<30 vs. 30–59 years<30 vs. ≥60 years30–59 vs. ≥60 years
Female sex, n (%)71 (71)83 (55)276 (47)0.011<0.0010.088
Age at investigation, median (IQR)70 (65–75)64 (61–70)74 (69–80)<0.001<0.001<0.001
Years between first syncope and investigation, median (IQR)54 (46–60)11 (5–20)2 (1–5)<0.001<0.001<0.001
Total no. of syncopes, median (IQR)8 (3–20)6 (3–10)3 (2–6)0.001<0.0010.003
Supine SBP, mean ± SD145 ± 19141 ± 22144 ± 230.2560.9100.143
Supine DBP, mean ± SD77 ± 1175 ± 1274 ± 120.3160.0260.222
Supine HR, mean ± SD70 ± 1270 ± 1270 ± 120.8040.6890.902
Prodromes, n (%)51 (52)52 (34)149 (26)0.020<0.0010.113
Palpitations, n (%)13 (13)28 (19)71 (12)0.1460.1860.136
Dizziness upon standing, n (%)69 (69)98 (65)398 (68)0.5000.8840.431
Hypertension, n (%)40 (40)70 (47)341 (59)0.3070.0010.009
History of CAD, n (%)8 (8)15 (10)79 (14)0.6090.1290.241
Heart failure, n (%)2 (2)8 (5)50 (9)0.1980.0240.186
Atrial fibrillation, n (%)9 (9)13 (9)113 (20)0.9210.0130.002
VVS, n (%)39 (39)47 (31)108 (19)0.198<0.0010.001
OH, n (%)7 (7)21 (14)133 (23)0.089<0.0010.017
CSS/CSH, n (%)4 (4)8 (5)54 (9)0.6370.0820.120
Complex syncope, n (%)37 (37)45 (30)152 (26)0.2340.0230.351
PPS, n (%)0 (0)1 (1)1 (0.2)0.4150.6970.302
No diagnosis, n (%)13 (13)29 (19)135 (23)0.1970.0230.299
Clinical featuresFirst syncopeP-value
<30 years (n = 100)30–59 years (n = 151)≥60 years (n = 585)<30 vs. 30–59 years<30 vs. ≥60 years30–59 vs. ≥60 years
Female sex, n (%)71 (71)83 (55)276 (47)0.011<0.0010.088
Age at investigation, median (IQR)70 (65–75)64 (61–70)74 (69–80)<0.001<0.001<0.001
Years between first syncope and investigation, median (IQR)54 (46–60)11 (5–20)2 (1–5)<0.001<0.001<0.001
Total no. of syncopes, median (IQR)8 (3–20)6 (3–10)3 (2–6)0.001<0.0010.003
Supine SBP, mean ± SD145 ± 19141 ± 22144 ± 230.2560.9100.143
Supine DBP, mean ± SD77 ± 1175 ± 1274 ± 120.3160.0260.222
Supine HR, mean ± SD70 ± 1270 ± 1270 ± 120.8040.6890.902
Prodromes, n (%)51 (52)52 (34)149 (26)0.020<0.0010.113
Palpitations, n (%)13 (13)28 (19)71 (12)0.1460.1860.136
Dizziness upon standing, n (%)69 (69)98 (65)398 (68)0.5000.8840.431
Hypertension, n (%)40 (40)70 (47)341 (59)0.3070.0010.009
History of CAD, n (%)8 (8)15 (10)79 (14)0.6090.1290.241
Heart failure, n (%)2 (2)8 (5)50 (9)0.1980.0240.186
Atrial fibrillation, n (%)9 (9)13 (9)113 (20)0.9210.0130.002
VVS, n (%)39 (39)47 (31)108 (19)0.198<0.0010.001
OH, n (%)7 (7)21 (14)133 (23)0.089<0.0010.017
CSS/CSH, n (%)4 (4)8 (5)54 (9)0.6370.0820.120
Complex syncope, n (%)37 (37)45 (30)152 (26)0.2340.0230.351
PPS, n (%)0 (0)1 (1)1 (0.2)0.4150.6970.302
No diagnosis, n (%)13 (13)29 (19)135 (23)0.1970.0230.299

The Bonferroni-adjusted significance level was set at P = 0.017.

SBP, systolic blood pressure; DBP, diastolic blood pressure; HR, heart rate; CAD, coronary artery disease; VVS, vasovagal syncope; OH, orthostatic hypotension; CSH, carotid sinus hypersensitivity; CSS, carotid sinus syndrome; PPS, psychogenic pseudosyncope; SD, standard deviation; IQR, interquartile range.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close